Skip to content

Comparing Herbal Medicine and Conventional Medicine for the Treatment of Heavy Menstrual Bleeding in Women

Comparative Efficacy of Darvyadi Kwatha verses Tranexamic acid 500mg in the management of Raktapradara (Menorrhagia): A Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095016
Enrollment
64
Registered
2025-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

Mahatma Gandhi Ayurved College, Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Written informed consent from patients willing to participate in the study Females aged 19 to 40 years presenting with classical symptoms of Raktapradar Menorrhagia Women with a baseline PBAC score indicating mild to moderate menorrhagia PBAC score between 100 and 300 will be included in the study Complaints of excessive more than 80ml and or prolonged more than or equal to 8days menstrual bleeding Regular menstrual history for the past three cycles prior to enrollment

Exclusion criteria

Exclusion criteria: Patients with known systemic illnesses such as tuberculosis or immunocompromised status Structural or malignant reproductive tract disorders based on clinical evaluation Current use of hormonal therapy oral contraceptive pills or intrauterine contraceptive devices IUCD Patients with bleeding disorders or those on anticoagulant therapy History of ongoing pelvic inflammatory disease Patient unwilling or unable to comply with study requirements

Design outcomes

Primary

MeasureTime frame
Exploring the efficacy of interventions in managing the full spectrum of Raktapradar Menorrhagia including moderate bleeding regular cycles pelvic discomfort weakness and systemic symptoms with assessment via PBAC score and clinical responseTimepoint: 2 Months

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Shruti Prakash Bhandari

Mahatma Gandhi Ayurved College, Hospital and Research Centre Salod(H) WardhaA

dr.bhagyashrichaudhari@gmail.com9096415920

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026